To clarify the possible mechanism between IL–20 and tumor progression, the signal molecules of ERK1/2, AKT, NF-κB, and p38 were assessed and found to be phosphorylated in IL-20-treated PC–3 cells (Fig 5F). The gene discussed is IL20; the disease is neoplasm.